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ABSTRACT 
Staphylococcus pseudintermedius is a common bacterial pathogen of pets associated with skin 
infections, that in 2006 was discovered to be able to infect humans and cause serious health 
conditions. This zoonotic potential, associated with a capacity to acquire and express antibiotic 
resistances and, most importantly for this study, the ability to form biofilms, makes it a strong 
cause for concern in both veterinary and human medicine. 
Medical grade manuka honey has been used to treat surface wounds as well as skin infections, 
with demonstrated antimicrobial effect over Staphylococcus aureus and Pseudomonas 
aeroginosa. 
With these two premises in mind, the goal of this study was to demonstrate that the same 
antimicrobial effect would be observable over biofilm-producing S. pseudintermidius, across 20 
clinically isolated isolates from dogs. To perform this assessment, three methods of data 
collection were chosen: crystal violet staining, Live/Dead Staining and Scanning Electron 
Microscopy. Respectively, these technics were used to measure biomass reduction, viability 
and morphology. 
Our results showed that across all isolates there was a general reduction in biomass and a 
massive decrease in viability. Unfortunately, we were unable to gather data on the morphology. 
Nevertheless, we were able to conclude that manuka honey does in fact have antimicrobial 
properties over S. pseudintermedius, even in the presence of mature biofilms. 
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ABBREVIATIONS  
 
ABS Absorbance 
CFU Colony Forming Units 
DH2O Deionized Water 
g grams 
L/D Live/Dead 
MHA Mueller-Hinton Agar 
MHB Mueller-Hinton Broth 
mL millilitres 
mm millimetres 
MRSA Methicillin Resistant S. aureus 
nm namometers 
ºC Degrees Celsius 
OsO4 osmium tetraoxide 
PBS phosphate-buffered saline 
SEM Scanning Electron Microscopy 
W/V weight per volume 
μl microliters 
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INTRODUCTION 
It is known that Staphylococcus pseudintermedius is a common cause of skin infections in dogs 
(Bannoehr & Guardabassi, 2012). It also has a significant zoonotic potential, first reported in 
humans in 2006, causing serious opportunistic infections (Hoovels, et al., 2006). This exceptional 
status among biofilm-associated pathogens is due to the emergence of multidrug-resistance 
associated with a wide range of virulence factors. During the last decade, there has been an 
increasing awareness of the potential problems that selection for antimicrobial resistant bacteria 
among companion animals may cause on human health, due to the increasing utilization of the 
same antimicrobial substances in human medicine and to the close contact between pets and 
their human co-habitants (Martins, et al., 2015). 
 
This steady increase in antimicrobial resistance over time propels the search for new compounds 
and molecules that might be used as therapies for cases where the commonly used antibiotics 
fail. This comes with a massive problem, because the pharmaceutical industry does not consider 
the research of new antibiotic molecules to be a profitable path to take. This comes at no surprise 
when we consider that these treatments are used for short periods of time, are often low cost and 
their use is restricted by the fact that microbes will become resistant to these new molecules, so 
using them sparsely is advisable. This means that the economic appeal of this research is virtually 
non-existent, with 80% of companies abandoning the field (Ventola, 2015). 
With that in mind, looking for naturally occurring alternative therapies is extremely important. 
 
From historical sources we know that humans have been using natural honey as a form of 
medicine for more than 8000 years, and with a reported inhibitory effect over more than 60 
species of bacteria, fungi and viruses. These effects come from a variety of different substances 
in its complex chemical composition, from antioxidant power to peptides, organic acids, phenols, 
enzymes and products of Maillard reactions (Eteraf-Oskouei & Najafi, 2013). 
 
Manuka honey in particular has been shown to inhibit many bacterial pathogens, including 
Methicillin Resistant S. aureus, and is successfully used in clinical practice for the treatment of 
surface wounds and wound dressing (Jenkins, et al., 2011). It has been recognized that manuka 
honey can act synergistically when combined with antibiotics against S. aureus and P. aeruginosa 
in vitro. (Cooper & Jenkins, 2012) This specific kind of honey is of great interest because it has 
the highest known concentration of methylglyoxal, the compound that, as far as we know, is 
responsible for most of honey’s antimicrobial effects (Henle, et al., 2008). 
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The research group I had the pleasure of cooperating had already published on the usage and 
the inhibitory effect of manuka honey over bacteria, like S. aureus and P. aeruginosa, and was 
working at the time to determine the ability of manuka honey to inhibit S. pseudintermedius growth 
alone and in combination with antibiotics, as well to determine its capacity to modulate virulence 
within S. pseudintermedius.  
My part in this study was to determine the effectiveness of manuka honey in the reduction of 
biofilms after their formation, what would have the implications on the capacity to treat chronic 
infections and possible use for prevention on surgical sites. 
Biofilms can be the causes of chronic infections in patients, forcing more aggressive therapies 
and sometimes even requiring surgery to remove. Most biofilms require treatment with an 
antibiotic concentration at least four times higher than those used to eliminate planktonic cell 
infections (Pompilio, et al., 2015). 
 
In order to monitor biofilm disruption and inhibition of growth a variety of methods and techniques 
can be used to measure bio-mass, viability and total cell count. 
Our research group focused on 20 isolates of S. pseudintermedius obtained from infections in 
cats and dogs with possible zoonotic potential, inferred from their earlier work. We selected crystal 
violet staining to determine reduction in biomass, fluorescent staining to determine viability and 
scanning electron microscopy for cell counts and morphology.  
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CLINICAL SIGNIFICANCE OF S. PSEUDINTERMEDIUS 
S. pseudintermedius is one of the younger members of the Staphylococcus genus, being 
described as its own species only in 2005 with the first reported case in humans in 2006 (Hoovels, 
et al., 2006). Like other members of this group of gram-positive cocci, S. pseudintermedius are 
capable of producing coagulase, DNAse and beta-haemolysin (Devriese, Vancanneyt, & Baele, 
2005). 
 
S. pseudintermedius is now known as one of the leading causes of skin, ear, and post-operative 
bacterial infections in pets, specially in dogs, where it is thought to be a presence in the skin of 
up to 90% of them (Joseph E. Rubin, 2011); in addition, it has been identified in other pets like 
cats and horses. As in other bacterial skin infections, the symptoms are non-specific, consisting 
of mainly pustules, scaling, hair loss and redness. 
Because of the cohabitation between dogs and humans, zoonotic infections have been reported 
in increasing numbers over the course of the last decade and it is now known to be able to cause, 
soft tissue infections, infection of surgical wounds, rhinosinusitis, and catheter-related 
bacteraemia (Somayaji, et al., 2016).  
 
As these bacteria have been studied it was discovered that, when associated to wounds, S. 
pseudintermedius is able to create biofilms. These biofilms make infections much harder to treat. 
One potential reason for this increased resistance is the penetration barrier that biofilms may 
present to antimicrobials. This biofilm production is consistent with the common diseases that 
they end up causing, generally chronic where treatment is very ineffective, which indicates some 
level of correlation between them (Pompilio, et al., 2015). 
Furthermore, S. pseudintermedius is often difficult to distinguish from S. intermedius and S. 
aureus, that as we know is one of the most important hospital infection pathogens, known to be 
able to become resistant to a multitude of antibiotics. In this regard, methicillin resistant strains 
(MRSA) are specially important. This means that there is a high likelihood of S. pseudintermidius 
having similar capacity to achieve resistance (van Duijkeren, et al., 2011). 
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Table 1: Some biochemical characteristics of Staphylococcus coagulase positive species. 
 S. pseudintermedius S. intermedius S. aureus 
Colony morphology Round, grey, opaque. 1-2 
mm 
Round, white, opaque, 2-4 
mm 
Round, grey/yellow, 
opaque, 2-3 mm 
Gram + + + 
Metabolism Facultative anaerobic Facultative anaerobic Facultative anaerobic 
Catalase/Oxidade +/- +/- +/- 
Coagulase + + + 
DNAse +   
Esculiase -  - 
Urease + + + 
 
With such similar biochemical properties, to differentiate between these species, purple agar with 
maltose is generally used since S. pseudintermedius is negative or weakly positive for this 
carbohydrate when under aerobic conditions on agar plates (Franklin, 2006; Olsson Ranta, 2004; 
Persson, 2002; Devriese, 2005). 
 
The Biofilm problem 
A biofilm is defined as a community of bacterial cells that become irreversibly attached to 
biological or environmental surface, producing a matrix of polysaccharide material, but also 
containing other materials, both biological in nature or gathered from their surroundings (Donlan 
R. M., 2002). These structures (created by a mechanism of quorum sensing) increase the ability 
of bacterial cells to survive adverse conditions, creating a physical barrier between the community 
and the environment, protecting the cells from the host’s immune response and from possible 
antibiotic therapies. The mechanisms by which a microorganism uses biofilms to acquire 
antimicrobial resistances can be intrinsic to the particular species or be acquired (e.g. plasmid). 
The polysaccharide matrix decreases the diffusion rate of antibiotics, both by physically stopping 
their movement and by reacting with the active substances. Furthermore, cells within biofilms 
often have lower replication rates, leading to a decreased uptake of antimicrobial compounds by 
cells. Lastly, the cells biochemical processes are altered within biofilms, affecting the mechanism 
of action of antimicrobial compounds (Donlan R. M., 2001). 
 
Biofilms also facilitate the creation of nutrient gradients and the genetic exchange (Donlan R. M., 
2002). The acquisition of resistances from plasmids in the environment is also a strong factor to 
be considered, since biofilms make it easier for bacteria to conjugate, both because of 
environmental stability and because of increased cell contact and proximity (Donlan R. M., 2001).  
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In the specific case of Staphylococcus infections, genetic testing has showed that species, like S. 
aureus and S. epidermidis, have all the necessary genes to create biofilms and perform horizontal 
gene transfer while equipped with antimicrobial resistance genes (Águila-Arcos, et al., 2016). 
All these characteristics of biofilms make them a very important problem in surface hygiene, 
medical equipment and chronic infections, added to the fact that standard broth micro-dilution 
techniques to test antimicrobial resistances will not accurately predict their efficiency against 
biofilms (Donlan R. M., 2001). 
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MANUKA HONEY AND ITS ANTIMICROBIAL POTENTIAL 
The manuka bush, also known as the western tea tree is a plant indigenous to New Zealand that 
was imported from Australia, home to at least other 80 other related species. Manuka honey is, 
as the name implies, produced by honeybees foraging on the nectar of manuka bushes. For a 
long time, the exact components responsible for the antibiotic properties were unknown, but we 
know now that the most likely culprit for most of its effects is methylglyoxal, a by-product of 
glycolysis (Henle, et al., 2008). Manuka honey demonstrates a antibiotic potential over a wide 
range of pathogens associated with wound infections, and has shown that effect on both antibiotic 
susceptible and resistant isolates with comparable efficiency (Cooper, et al., 2002). 
 
In S. aureus, with particular importance in the case of MRSA, the antibiotic effect of manuka 
honey is linked to the interruption of cell division, where the daughter cells are unable to separate 
from each other leading to bi-lobed cells with fully formed cross-walls. This is caused by the loss 
of activity of some autolysins that the bacteria uses to cleave the peptidoglycan in its walls 
(Henriques A, 2009; Jenkins R E, 2011). Furthermore, manuka honey also appears to down-
regulate stress proteins, making the cells more sensitive to environment changes and less 
capable of adaption to new conditions (Jenkins, et al., 2011). Manuka honey has also been used 
in MRSA infections to reverse the resistance to oxacillin (Jenkins RE, 2012). 
 
With such a vast array of inhibitory effects, everything indicates that manuka honey is a good 
candidate for usage in cleaning and also preventing open wound infections, and has already been 
proved to work on several human patients for conditions like a leg ulcer (Natarajan S & D, 2001), 
diabetic foot ulcers (Eddy JJ, 2005), maxillofacial wounds (Visaveda, Honeysett, & Danford, 2008) 
and even paediatric oncology patients (Blaser, et al., 2007). 
 
There is also another factor that we should take into account. Every time a new molecule is 
introduced and used in clinical therapies, there is a high likelihood of resistances to emerge, with 
the only real difference being the time that it takes for those resistances to manifest themselves. 
With such a variety of different antimicrobial effects, targeting such a wide range or biochemical 
processes, the likelihood that bacteria could become resistant to honey is very low, and as far as 
current training experiments indicate, there isn’t a selection for honey-resistant mutants (Cooper, 
et al., 2010). 
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MATERIALS AND METHODS 
DISRUPTION OF S. PSEUDINTERMEDIUS BIOFILMS BY MANUKA HONEY 
Specimen Colony Growth and Biofilm production set up 
To assess the inhibitory effect of manuka honey, 20 clinical isolates of S. pseudintermedius 
isolated from the skin of dogs from several clinical partners of the University of Swansea and the 
Cardiff Metropolitan University. For confidentiality reasons, I was not provided with any further 
detail regarding the clinical case of any of those patients. The isolates are referred to with the 
letters A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, T, U and X. 
 
The materials used for this stage were Mueller-Hinton broth (MHB) and Mueller-Hinton agar 
(MHA), prepared in the concentrations advised by the manufacturer. Various pipette tips, plastic 
petri dishes, sterile phosphate buffered saline (PBS), sterile plastic petri dishes, 10ul plastic 
inoculation loops, 96 well plates, Cryobeads and falcon tubes were also needed.  
The bacterial samples used were retrieved from Cryobeads stored at -80ºC.  
Honey solutions were prepared using MediHoneyTM manuka honey at 10%, 20%, 30%, 40% and 
50% weight per volume (w/v) concentrations. To obtain a 10% w/v manuka honey solution, 10g 
honey was weighed into a sterile falcon tube then sterile MHB was added up to the 100 ml mark 
on the tube. The tube was sealed and shaken until the honey was fully mixed in. If it was too hard 
to dissolve, a warm water bath could be used, but I that was never the case during the experiment.  
 
The method used worked on a 3-day timeline. On day one, bacterial isolates were obtained from 
-80ºC freezer. A sterile plastic pipette tip was used to remove one Cryobead from the container. 
The bead was carefully rolled on the surface of the MHA plate ensuring the creation of a large 
inoculum. Once this step finished, a sterile plastic loop was used to streak for single colonies. 
Alternatively, the bead could have been placed directly into 5mL of sterile MHB rather than a 
plate, however, if using this technique, the solution should be gram stained or streak onto solid 
agar after incubation to ensure bacterial purity. Inoculated plates were then incubated at 37ºC for 
24-48 hours to ensure a high quantity and quality of growth. 
 
On the second day, the inoculated plates were checked to ensure that the growth was suitable 
and pure (if necessary single colonies could have been isolated for gram staining to ensure purity 
of cultures, which we did not deem necessary) and a sterile plastic loop was used to touch 3-4 
colonies from said plates. Then the loop was used to create a solution of the bacterial isolate in 
sterile MHB. Volumes of the bacterial solution varied depending on the amount of samples tested 
per week, a number that for various reasons was not consistent. 
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To ensure accurate preparation of bacterial suspension, spectrophotometry was used. The 
spectrophotometer was set to 600nm for all samples and it was blanked with a 1cm cuvette 
containing 1mL of sterile MHB. 
Once the machine was set to 0, the optical density of the bacterial suspension was checked and 
it should be equal to 0.08-0.1 Absorbance (ABS) as this value is equal to a 0.5 McFarland 
Standard or 10^8 CFU/mL. When the absorbance was low, the concentration was increased by 
adding additional bacteria via sterile plastic loop. On the other hand, the solution could be further 
diluted using sterile MHB, if the absorbance was high. This can also be done by further dilution 
of original inoculum. 
For the next step, a 96 well plate was prepared and 100 μL of sterile broth was pipetted in a sterile 
fashion into the required wells on the plate. Then, 100 μl of the previously prepared 0.5 
Macfarlane standard bacterial suspension was inoculated into all wells that were required on the 
96 well plate. 
A series of wells were left bacteria free to serve as a negative control, these wells were also 
inoculated last with an additional 100 μL of sterile MHB. 
The plates were then left to incubate for 48 hours at 37ºC, with a replacement of media at the 24h 
mark. 
 
On the third day and once the desired time had passed, the biofilm development was visually 
confirmed. Wells with biofilm appeared turbid and the negative control wells showed up clear. 
A multi-channel pipette was used to remove all the liquid from inside the wells of the well plate, 
making sure that the process was performed in a very careful manner not to compromise the 
integrity of the biofilm. 
Once empty, the wells were carefully washed twice with 200μl of PBS and then all liquid from the 
wells was removed, washing with it all traces of broth and planktonic cells. 
All the biofilms to be tested were then inoculated with solutions containing the desired 
concentrations of 10%, 20% ,30% ,40% and 50% of honey and sterile MHB. 
The first set of wells was kept honey free as a positive control and the last well row was kept 
bacteria free as a negative control. 
Plates were then incubated for 18 to 20 hours at 37ºC (EUCAST, 2003). 
Crystal Violet Staining 
Cells tend to detach from the well walls as they die and this characteristic can be used for the 
indirect quantification of cell death and to determine differences in proliferation upon stimulation 
with antimicrobial compounds. One method to detect maintained adherence and biomass of cells 
is staining the bacterial cells with crystal violet dye, which binds to proteins and DNA. In theory, 
the cells that die lose their ability to adhere and are subsequently lost from the sample during the 
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washing stages of the procedure, reducing the amount of crystal violet in the sample (O'Toole, 
2011). 
 
The materials used at this stage were the pre-prepared inoculated 96 well plates, various pipette 
tips, plastic petri dishes, PBS, 0.1% Crystal Violet solution, (200μl of 20% Crystal Violet and 
39.8mL of sterile deionized water (DH2O)), 7% acetic acid (2.8mL of glacial acetic acid and 
37.2mL of sterile DH2O), and 99% pure methanol. 
 
At this stage the pre-established biofilm was treated with concentrations of honey and the effects 
were measured by first removing all planktonic cells and growth media. Using a multi-channel 
pipette, all the liquid from inside the wells of the well plate was carefully removed, making sure to 
keep the biofilm integrity. Once empty, each well was carefully washed twice again with 200 μl of 
PBS using a multi-channel pipette, aspirating all liquid from the wells after washing to remove all 
traces of broth and planktonic cells. Then, each well was filled with 200 μl of methanol and 
incubated at room temperature for 30 minutes, this process ensured that the biofilms were fixated 
to the plate. After that time, we proceeded to remove the residual methanol from each well and 
allow it to air dry further for 30 minutes. Next, each well was filled with 200 μl of 1% Crystal Violet 
solution and incubated at room temperature for another 15 minutes, after which the solution was 
aspirated from all the wells, removing as much as possible. Each well was then washed twice 
with 200 μl of PBS, aiming to remove as much dye and planktonic cells as possible. If it was 
necessary, the washing step was repeated up to 3 times. At this point, the biofilm was fixated and 
less prone to disruption via pipetting, but care was still taken. The last processing stage was to 
add 200 μl of 7% Glacial acetic acid to each well and then let the plates incubate for 15 minutes 
at room temperature.  The final step was reading the plates on the Nanostar Plate Reader set to 
a wavelength of 570nm (O'Toole, 2011). 
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Figure 1. Set up and materials of crystal violet staining. 
 
Live/Dead (L/D) Staining 
The kit we used, LIVE/DEAD BacLightTM Bacterial Viability, utilizes mixtures of SYTO® 9 green-
fluorescent nucleic acid stain and the red-fluorescent nucleic acid stain propidium iodide. These 
stains differ in their spectral characteristics and in their ability to penetrate healthy bacterial cells 
making it a good method to differentiate viable cells from dead ones. The SYTO® 9 dye stains all 
bacteria in a population whether they possess intact membranes or damaged membranes. In 
opposition, propidium iodide is only capable of penetrating bacteria with damaged membranes, 
causing a reduction in the SYTO® 9 fluorescence when both dyes are present. Because of these 
characteristics, an appropriate mixture of the SYTO® 9 and propidium iodide dyes will stain 
bacteria with intact cell membranes fluorescent green, and bacteria with damaged membranes 
fluorescent red. 
 
For this stage the materials needed were the staining kit “L7007 LIVE/DEAD® BacLightTM 
Bacterial Viability Kit for microscopy”, PBS and 24 well plates that were prepared by following the 
same method for colony growth as the 96 well plates referred in the first protocol of this chapter, 
with the addition of a glass slip to the bottom of each well. Using a multi-channel pipette, we 
started by carefully removing all the liquid from inside the wells of the well plate, in order to keep 
the biofilm integrity preserved. Once empty, each well was washed twice and very carefully with 
1ml of PBS using a single channel pipette, aspirating all liquid from the wells after the washing to 
remove all traces of broth and planktonic cells. 
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Then, equal volumes of Component A, the SYTO® 9 dye, and Component B, propidium iodide 
were combined and mixed thoroughly in a microfuge tube. Next, it was supposed to add 3 μL of 
the dye mixture per mL of the bacterial suspension but, since we were working with biofilm, we 
added 20 μL to each well, that was enough to cover the slip at the bottom, where the biofilms we 
were interested in had formed. After mixing thoroughly again, we incubated them at room 
temperature in the dark for 15 minutes. After that the glass slip was taken out of each well and 
put it on top of a glass slide, covering it with a glass lamella. Finally, we observed the samples in 
a fluorescence microscope, taking 5 representative pictures of each of them, at a magnification 
of 200 times (Molecular Probes, 2004). 
 
 
Figure 2. Layout of 24-well plates for L/D and SEM 
 
Scanning Electron Microscopy  
In scanning electron microscope (SEM), a type of electron microscope is used that produces 
images of a sample by scanning the surface with a focused beam of electrons. These electrons 
will interact with the atoms in the sample, producing various signals that contain information about 
the sample topography and, depending on the method used, even composition. The electron 
beam is scanned in a raster scan pattern, and the beam's position is combined with the detected 
signal to produce an image, making it capable of achieving resolutions in the order of 1 nm. 
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We used conventional high vacuum SEM for our experiment, but low vacuum, wet conditions, 
variable pressure and environmental SEM, at a wide range of very low or very high temperatures 
is also possible with the right specialized instruments.  
Biological samples however are not very good at reflecting focused electron beams, so a metal, 
in this case gold, coating is needed to ensure that the sample is able to produce the right kind of 
electron scatter. 
 
Materials needed for this method were 3% glutaraldehyde at 37ºC, PBS, 1% Osmium tetraoxide 
(OsO4),1% carbohydrazide, distilled water, a graded series of ethanol at 30%, 50%, 70%, 90% 
and 100% and a 24 well plate prepared previously following the same method used for the L/D. 
Using a multi-channel pipette, we started by carefully removing all the liquid from inside the wells 
of the well plate, preserving the biofilm integrity. Once empty, each well was washed twice and 
very carefully with 1 mL of PBS using a single channel pipette, aspirating all liquid from the wells 
after washing to remove all traces of broth and planktonic cells. At the next step OsO4 was added 
to each well, enough to cover the glass slip, and then they were let to incubate at room 
temperature for 30 minutes. After the desired time had passed, the wells were rinsed slowly with 
PBS, up to 5 times when required. Carbohydrazide at 1% was then added, and once again they 
were let to incubate at room temperature for another 30 minutes. 
When the previous incubation was done, all the wells were rinsed with distilled water up to 5 times 
and 1% OsO4 was added and once again left to incubate at room temperature for 30 minutes. 
Following the last incubating period, another rinse was needed, using distilled water up to 3 times. 
The last step before drying was dehydration by progressively increasing ethanol concentrations. 
With starting concentrations of 30% and increasing it to solutions of 50%, 70%, 90%, and three 
times 100%, and waiting 3 to 5 minutes between them. 
When the sample was properly fixed and dehydrated, it was let to dry. Then the glass slip that 
had been placed at the bottom of each well was removed, being very careful not to break them 
because the dehydration processed tended to make them very prone to stuck to the plate, and 
placed on top of SEM stubs. The SEM stubs were loaded into a sputter and coated with 1-2 nm 
of a gold-palladium alloy. When the stubs were ready, they were loaded into the microscope itself. 
The SEM chamber was first vented, and the chamber was allowed to reach nominal pressure 
indicated by a gauge on screen. The SEM sample compartment was opened and the sample 
stage was taken out, all the samples were loaded into it (7 samples could be loaded at any given 
time), and the screws were tightened up to secure the stubs to the stage. If all the 7 stub spaces 
were used, the centre sample was loaded in first place, because it’s easier to tighten the centre 
screw, if no other sample is loaded at the time. The sample stage was put back into the sample 
chamber and the compartment closed. 
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Finally, the pumps were turned on and the system allowed to reach vacuum. The microscope was 
then ready to be used, taking 3 to 5 representative pictures from each stub (Fischer, et al., 2012). 
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RESULTS
The below graphs show the variance in absorbance as the percentage of w/v of honey increases. 
This value was proportional to the amount of biomass stained by the crystal violet. All the 20 
isolates showed a reduction in biomass, but the strength of the effect was highly dependent on 
the isolate. The mean reduction for biomass seems to peak at a concentration of 40% of honey, 
while a 10% honey concentration was actually detrimental to reduction as shown.  
 
 
 
 
Figure 3: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample A. 
 
Figure 4: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample B. 
 
 
 
Figure 5: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample C.
 
Figure 6: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample D. 
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Figure 7: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample E. 
 
Figure 8: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample F. 
 
Figure 9: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample G.
 
Figure 10: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample H. 
 
Figure 11: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample I. 
 
Figure 12: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample J. 
 
Figure 13: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample K. 
 
Figure 14: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample L. 
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Figure 15: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample M. 
 
Figure 16: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample N. 
 
Figure 17: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample O. 
 
Figure 18: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample P. 
 
Figure 19: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample Q. 
 
Figure 20: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample T. 
 
Figure 21: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample U. 
 
Figure 22: Relationship between honey concentration 
and absorbance for S. pseudintermedius’ sample  X.
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On average, the reduction in biomass was of -11,16% (which corresponds to an actual increase), 
14,25%, 35,37%, 44,22% and 42,86% for honey concentrations of 10%, 20%, 30%, 40% and 
50%, respectively. This is illustrated in Figure 23, where the tendency curve was obtain from the 
averages of all samples using a logarithmic regression.
 
 
Figure 23: Average of Biomass Reduction across all 20 isolates 
 
 
The following images show the results from the L/D staining, where green detonates viable, living 
bacterial cells, and red represents dead, unviable bacterial cells. The first thing that was easily 
noted was the decrease in cellularity as the concentration of honey goes up, as well as the 
reduction in viability. 
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Figure 24: L/D Image of sample P at 0% honey 
concentration and 200 times magnification. 
Figure 25: L/D Image of sample P at 10% honey 
concentration and 200 times magnification 
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Using a cell count with the ImageJ (National Institutes of Health) software, we have estimated an 
average dead percentage of 7%, 27%, 78% and 96% for the 0%, 10%, 30% and 50% honey 
concentrations respectively. These images were obtained for samples P and T, and are 
consistent across both of them. 
 
Regarding SEM images, it was possible to detect an important decrease in the number of cells 
when they were exposed to 30% and 50% honey concentrations, while still finding the same slight 
increase in biomass (we can’t be sure if those are cells or extracellular matrix at this magnification) 
under 10% honey solution. 
Figure 26: L/D Image of sample P at 30% honey 
concentration and 200 times magnification 
Figure 27: L/D Image of sample P at 50% honey 
concentration and 200 times magnification 
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Other higher magnification images were obtained, but after reviewing them we deemed them not 
high quality enough to be useful to draw conclusions. 
 
 
 
 
 
  
  
Figure 28: SEM Image of sample T at 0% honey 
concentration. 
Figure 29: SEM Image of sample T at 10% honey 
concentration. 
 
Figure 30: SEM Image of sample T at 30% honey 
concentration. 
 
Figure 31: SEM Image of sample T at 0% honey 
concentration. 
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DISCUSSION 
Results from crystal violet staining assays revealed that even though there was a clear reduction 
in biomass some other trends were also common. For instance, the increase in biomass that 
happened at 10% should be better explored, because two possible explanations can be argued: 
either there is an increase in the extracellular matrix when bacterial cell are under stress, or the 
bacteria might actually be able to use the honey has a nutrient source while the eventual antibiotic 
compounds are in lower concentrations. 
 
Crystal violet staining is straightforward to process great quantities of samples but its precision 
can become a problem because of its inherent ability to stain all forms of biological material, from 
DNA to proteins. Therefore, other technics of staining, like resazurin, might be advisable in the 
future. Still, the data provided by crystal violet is very promising, since the general decrease in 
biomass is still quantifiable and significant, especially when combined with other techniques that 
were used, namely L/D staining and SEM observation.  
 
Direct observations with L/D staining suggest that the reduction of viable bacterial cells when 
treated with honey was superior to the one we can infer from crystal violet test alone. Because of 
restrictions with access to lab equipment and facilities, this staining was only performed on two 
of the 20 isolates that we had available, chosen because their early results matched the average 
the closest, therefore doing the same for the rest of the samples would be strongly advisable. 
Even so, since the results from the two isolates tested were so similar and consistent, even 
matching the expected increase in biomass but with reduction in viability, it is expected that all 
the others would also perform the same way, meaning the individual values might be different but 
the same trend line is expected. 
 
Because the same restrictions regarding lab access were true for the SEM and because this 
method is even more time consuming than the previous one, only the same two samples were 
tested. Further problems arose from this technique regarding the focus of the microscope that we 
were using, that stopped me from being able to acquire pictures with a quality that would allow 
for any sort detail of the cell samples at higher magnifications, rendering the original idea of 
evaluating morphology impossible to actually accomplish. Knowing about morphological 
modifications in cells would have allowed us to predict what is the mean by which the honey is 
killing them, helping to steer the research that might come next and that being the biggest 
advantage of this methods and one that we were unable to use. 
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Lastly, in my opinion, the next step should be performing genetic testing to determine the 
modulation of virulence that might be occurring during this biofilm disruption since it would paint 
an even clear picture of the interactions that are occurring. 
 
Also, training tests, where bacteria are expose to increasing concentrations of one specific 
compound or substance to be tested, might be a good addition to the data, even if all the training 
tests in other bacterial species so far seem to indicate that they do not develop resistances to 
manuka honey. (Cooper, et al., 2010) 
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CONCLUSION 
At the start of this thesis, I set out to answer question: “Is manuka honey capable of disrupting 
fully formed S. pseudintermedius’ biofilms, and does it show an antibiotic effect over them.?” 
In the end, I was able to conclude that the answer is positive. Using the combination of technics 
we did, and with the scientific reasoning behind them, we can attest the ability manuka honey 
to, in vitro, disrupt S. pseudointermedius fully formed biofilms, as well as its antibiotic effect, 
inhibiting both viability and cellular counts, when in concentrations above 10% w/v. 
However, even though we were able to prove these capabilities, there are still problems 
surrounding it, as we still do not know exactly the mechanisms involved, or the optimal inhibitory 
concentrations. Furthermore, delivery methods will restrict the actual use of honey in clinical 
practice because it can not be used everywhere without heavy research into this topic. 
From a clinical perspective, considering the information available, wound care and surgical 
infections prevention are the strong suits for the use of these products. Where we would be 
using another topical antibiotic we can use honey, or a combination of honey with another 
antibiotic. 
Both veterinary and human medicine are fighting an arms race against antibiotic resistances by 
microorganisms, trying to innovate and create new molecules faster than they can adapt to what 
we use against them. This is particularly dramatic when a microorganism is able to hop from 
animals to humans, giving it more opportunity to become resistant and limiting the molecules 
that we can use in both groups. 
All that said, it is good to know that we still have weapons in the war, and that manuka honey is 
a tool we can add to our toolbox.  
 
  
24 
REFERENCES 
	
Águila-Arcos, S., Álvarez-Rodríguez, I., Garaiyurrebaso, O., Garbisu, C., Grohmann, E., & 
Alkorta, I. (October, 2016). “Biofilm-Forming Clinical Staphylococcus Isolates Harbor 
Horizontal Transfer and Antibiotic Resistance Genes.” Front Microbiol. 
Bannoehr, J., & Guardabassi, L. (April, 2012). “Staphylococcus pseudintermedius in the dog: 
taxonomy, diagnostics, ecology, epidemiology and pathogenicity.” Veterinary 
Dermatology, 4, 253-266 
Blaser, G., Santos, K., Bode, U., Vetter, H., & Simon, A. (2007). “Effect of medical honey on 
wounds colonised or infected with MRSA.” J. Wound Care, 8, 325-328 
Cooper, R. A., Jenkins, R. L., & Henriques, A. F. (2010). “Absence of resistance to medical grade 
manuka honey.” Eur. J. Clin. Microbiol. Infect. Dis, 10, 1237-1241 
Cooper, R. A., Molan, P. C., & Harding, K. G. (2002). “The sensitivity to honey of Gram-positive 
cocci of clinical significance isolated from wounds.” J. Appl. Microbiol, 5, 857-863 
Cooper, R., & Jenkins, R. (March, 2012). “Synergy between oxacillin and manuka honey 
sensitizes methicillin-resistant Staphylococcus aureus to oxacillin.” Journal of 
Antimicrobial Chemotherapy, 6, 1405-1407 
Devriese, L. A., Vancanneyt, M., & Baele, M. (2005). “Staphylococcus pseudintermedius sp. nov., 
a coagulase-positive species from animals.” Int J Syst Evol Microbiol, 4, 1569-1573 
Donlan, R. M. (October, 2001). “Biofilm Formation: A Clinically Relevant Microbiological Process.” 
Clinical Infectious Diseases, 8, 1387-1392 
Donlan, R. M. (September, 2002). “Biofilms: Microbial Life on Surfaces.” Emerg Infect Dis, 9, 
881-890 
Eddy JJ, G. M. (2005). “Topical honey for diabetic foot ulcers.” J. Fam. Pract, 6, 533-535 
Eteraf-Oskouei, T., & Najafi, M. (June, 2013). “Traditional and Modern Uses of Natural Honey in 
Human Diseases: A Review.” Iran J Basic Med Sc, 6, 731-742 
EUCAST. (2003). “Determination of minimum inhibitory concentrations (MICs) of antibacterial 
agents by broth dilution.” Clinical Microbiology and Infection. 
Fischer, E. R., Hansen, B. T., Nair, V., Hoyt, F. H., & Dorward, D. W. (May, 2012). “Scanning 
Electron Microscopy.” Curr Protoc Microbiol. 
Franklin, A., Greko, C., Andersson, U. G., & Bengtsson., B. (2006). “MRSA - now also in Swedish 
dogs.” Sv. Vet. Tim.  
Henle, E., Mavric, S., & Wittmann, G. B. (2008). “Identification and quantification of methylglyoxal 
as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys 
from New Zealand.” Molecular Nutrition and Food Research, 4, 483-489 
25 
Henriques, A., Jenkins, R., Burton, N., & Cooper, R. (2009). “The intracellular effects of manuka 
honey on Staphylococcus aureus.” Eur. J. Clin. Microbiol. Infect. Dis, 1, 45-50 
Hoovels, L. V., Vankeerberghen, A., Boel, A., & Kristien Van Vaerenbergh, a. H. (December, 
2006). “First Case of Staphylococcus pseudintermedius Infection in a Human.” JOURNAL 
OF CLINICAL MICROBIOLOGY, 12, 4609–4612. 
Jenkins RE, C. R. (2012). “Synergy between oxacillin and manuka honey sensitizes methicillin-
resistant Staphylococcus aureus to oxacillin.” J. Antimicrob. Chemother, 6, 1405-1407 
Jenkins, R., Burton, N., & Cooper, R. (September, 2011). “Manuka honey inhibits cell division in 
methicillin-resistant Staphylococcus aureus.” Journal of Antimicrobial Chemotherapy, 
11, 2536-2542 
Jenkins, R., Burton, N., & Cooper, R. (2011). “The effect of manuka honey on the expression of 
universal stress protein A in meticillin resistant Staphylococcus aureus.” Int. J. 
Antimicrob. Agents, 4, 373-376 
Joseph E. Rubin, M. C.-T. (2011). “Prevalence, sites of colonization, and antimicrobial resistance 
among Staphylococcus pseudintermedius isolated from healthy dogs in Saskatoon, 
Canada.” J Vet Diagn Invest, 2, 351-354 
Martins, L. L., Beça, N., Bessa, L. J., Mendes, Â., Santos, J. T., Matos, A. J., & Costa, P. M. 
(November, 2015). “Coagulase-Positive Staphylococcus: Prevalence and Antimicrobial 
Resistance.” Journal of the American Animal Hospital Association, 6, 365-371 
Molecular Probes. (2004). LIVE/DEAD® BacLight™ Bacterial Viability Kit. 
Natarajan S, W., & D, G. J. (2001). “Healing of an MRSA-colonised hydrowyurea-induced leg 
ulcer with honey.” J. Dermatol. Treat, 1, 33-36 
Olsson Ranta, L. (2004). “Staphylococci as food poisoning - a literature study.” Sv. Vet. Time . 
O'Toole, G. (2011). “Microtiter Dish Biofilm Formation Assay.” Journal of Visualized 
Experiments, 47 
Persson, P. W. (2002). “Testing of a new method for detecting Staphylococcus aureus at 
mastitis.” Sv. Vet. Time. 
Pompilio, A., De Nicola, S., Crocetta, V., Guarnieri, S., Vincenzo, S., Carreto, E., & Di 
Bonaventura, G. (2015). “New insights in Staphylococcus pseudintermedius 
pathogenicity: antibiotic-resistant biofilm formation by a human wound-associated strain.” 
BMC Microbiology, 15, 109 
Somayaji, R., Priyantha, M., Rubin, J., & Church, D. (August, 2016). “Human infections due to 
Staphylococcus pseudintermedius, an emerging zoonosis of canine origin: report of 24 
cases.” Diagn Microbiol Infect Dis, 4, 471-476 
van Duijkeren, E., Catry, B., Greko, C., Moreno, M., Pomba, M., Pyörälä, S., . . . Törneke, K. 
(December de 2011). “Review on methicillin-resistant Staphylococcus pseudintermedius.” 
J Antimicrob Chemother, 12, 2705-2714 
26 
Ventola, C. L. (April de 2015). “The Antibiotic Resistance Crisis Part 1: Causes and Threats.” 
Pharmacy and Therapeutics, 4, 277-283 
Visaveda, B., Honeysett, J., & Danford, M. (2008). “Manuka honey dressing: an effective 
treatment for chronic wound infections.” Br. J. Oral Maxillofac. Surg, 8, 696-697 
 
 
 
 
 
 	
27 
TABLE OF TABLES AND FIGURES 
Table	1:	Some	biochemical	characteristics	of	Staphylococcus	coagulase	positive	species.	.........................................	5	
	
Figure	1.	Set	up	and	materials	of	crystal	violet	staining.	...........................................................................................	11	
Figure	2.	Layout	of	24-well	plates	for	L/D	and	SEM	...................................................................................................	12	
Figure	3:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	A.	.............	15	
Figure	4:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	B.	.............	15	
Figure	5:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	C.	.............	15	
Figure	6:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	D.	.............	15	
Figure	7:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	E.	.............	16	
Figure	8:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	F.	.............	16	
Figure	9:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	G.	.............	16	
Figure	10:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	H.	...........	16	
Figure	11:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	I.	............	16	
Figure	12:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	J.	............	16	
Figure	13:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	K.	...........	16	
Figure	14:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	L.	............	16	
Figure	15:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	M.	..........	17	
Figure	16:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	N.	...........	17	
Figure	17:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	O.	...........	17	
Figure	18:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	P.	...........	17	
Figure	19:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	Q.	...........	17	
Figure	20:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	T.	...........	17	
Figure	21:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample	U.	...........	17	
Figure	22:	Relationship	between	honey	concentration	and	absorbance	for	S.	pseudintermedius’	sample		X.	..........	17	
Figure	23:	Average	of	Biomass	Reduction	across	all	20	isolates	................................................................................	18	
Figure	24:	L/D	Image	of	sample	P	at	0%	honey	concentration	and	200	times	magnification	...................................	18	
Figure	25:	L/D	Image	of	sample	P	at	10%	honey	concentration	and	200	times	magnification	.................................	18	
Figure	26:	L/D	Image	of	sample	P	at	30%	honey	concentration	and	200	times	magnification	.................................	19	
Figure	27:	L/D	Image	of	sample	P	at	50%	honey	concentration	and	200	times	magnification	.................................	19	
Figure	28:	SEM	Image	of	sample	T	at	0%	honey	concentration.	................................................................................	19	
Figure	29:	SEM	Image	of	sample	T	at	10%	honey	concentration.	..............................................................................	19	
Figure	30:	SEM	Image	of	sample	T	at	30%	honey	concentration.	..............................................................................	20	
Figure	31:	SEM	Image	of	sample	T	at	50%	honey	concentration.	..............................................................................	20	
 
 
 
